Published June 30th, 2015 by Stephanie
The increased attention that the pharmaceutical industry has placed on HCV or the Hepatitis C virus may eventually lead to a reduction of the burden that is associated with this infectious disease. Indeed, the scope of this issue now encompasses a combination of medications that are in the clinical development stage. As a result, the medical industry has been anticipating some significant advances for the treatment of this disease from 2015 forward. Furthermore, that progress is moving at a rapid pace.
According to HealthDay reporter Amy Norton in an article published in HealthDay News, these new Hepatitis C medications currently in development promise a successful cure rate of 90% or higher. Unfortunately, the price tag attached to them could be cost-prohibitive for private and public health insurance providers alike. However, the prescription drugs that have been introduced to this point are now considered the type of breakthroughs that could eventually make this infectious liver disease a rarity here in the US.
But with prices exceeding a per pill cost of $1,000, government and private insurance companies are strongly objecting and are oftentimes placing limits or restrictions as to which patients will be qualified to take these medications. In the March 16th, 2015 issue of the Annals of Internal Medicine, two research studies concluded that treating Hepatitis C with these new drugs can be very cost-effective for the individual patient based on their efficacy. The conclusion is taking into account how physicians and scientists have calculated the additional years of improved health and the better quality of life that they will enjoy.
You’re probably saying to yourself “So tell me the bad news.” One recent research study has implied that private insurers and state governments will likely spend an additions $65 billion between now and 2020 in order to see that every eligible American can get these drugs. But that $65 billion is not going to be offset by the approximate $16 billion that is saved by not having to treat as many Americans with these medications. One of the biggest arguments favoring these different medications is that it will save money.
Unfortunately, it is difficult to say whether or not insurance coverage and a medication assistance solution is out there where the cost of Hepatitis C treatment drugs and other prescription prices are concerned. However, just about anyone can save money on their other medications by using the USA Rx pharmacy discount card. Not only can your realize savings of up to 75% on certain medications, the card is now accepted at over 60,000 US pharmacies. To start saving money on your prescriptions today, contact USA Rx at 888-277-3911 or if you prefer, you can e-mail us at [email protected].